Overview

Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of diclofenac diethylamine 2.32% gel in the treatment of acute ankle sprain.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Diclofenac